By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Gene Logic Inc. 

50 West Watkins Mill Road

Gaithersburg  Maryland  20878  U.S.A.
Phone: 301-987-1700 Fax: 301-987-1701


Gene Logic: Your Partner in Drug Development

Gene Logic provides innovative drug discovery and development solutions to the pharmaceutical industry. Our solutions span the pharmaceutical development pipeline, helping customers develop therapeutically and commercially valuable compounds in a more timely, efficient, and cost-effective manner. Our customers can use our solutions to understand the effect of a compound on biological processes, and to identify, evaluate and measure critical safety, efficacy, and other patient-related factors so that they may better assess the likely therapeutic and commercial value of their targets and compounds.

Our portfolio of solutions consists of:

Genomics and Toxicogenomics: We help customers to discover and prioritize drug targets, identify biomarkers, predict toxicity and provide insights into efficacy of specific compounds through the use of gene expression technologies, proprietary reference databases and bioinformatics software and professional services. Specific products and services include:

  • BioExpress® System
  • ASCENTA® System
  • ToxExpress® System
  • ToxScreen™ Reports
  • Mechanism of Toxicity (MOT) Reports
  • Genesis Enterprise System® Software
  • Microarray Data Generation and Analysis™ Services

    Preclinical Services: We enable customers to assess the safety and pharmacologic effects of candidate compounds with the intention of gaining regulatory approval to proceed with human trials on prioritized compounds, through testing research studies and related laboratory services. Specific study services include:

  • General Toxicology
  • Reproductive and Developmental Toxicology
  • Safety Pharmacology
  • Bioanalytical Services
  • Pathology Services
  • Clinical Pathology Services

    Drug Repositioning and Selection™ Program: We work with pharmaceutical companies to find new development paths for failed, stalled, or deprioritized clinical-stage drug candidates, to prioritize promising lead candidates, or to identify additional applications for marketed drugs. Our unique, integrated multiple technologies allow us to assess hundreds of human disease therapeutic indications for each drug candidate. Specific partnership arrangements include:

  • Drug Repositioning
  • Compound Selection
  • Market Expansion

    By thinking as a partner – listening to our clients and understanding their needs – Gene Logic provides customers with the insights to find the full therapeutic and commercial potential within each drug candidate in their developmental pipeline.

    Last Updated: 04-06-2006

    Key Statistics

    Ownership: Public

    Web Site: Gene Logic Inc.
    Employees: ~400 (Q1 2006)
    Symbol: GLGC

  • Industry


    Company News
    Transgenomic, Inc. (TBIO) Acquires Clinical Sample Biorepository from Gene Logic Inc. (GLGC) 5/24/2012 10:24:56 AM
    Gene Logic Inc. (GLGC), an Ocimum Biosolutions Inc. Company Announces Special Academic Pricing for ASCENTA 4.0 to Celebrate its 10th Anniversary 4/11/2011 10:29:44 AM
    Gene Logic Inc. (GLGC) Announces Appointment of Norrie Russell as President 9/2/2010 12:42:32 PM
    Gene Logic Inc. (GLGC) Ramps Up Genomics Momentum 3/18/2009 10:13:42 AM
    Genstruct, Inc. and Gene Logic Inc. (GLGC) Collaborate on Systems Toxicology 2/25/2009 11:52:29 AM
    Gene Logic Inc. (GLGC) Announces Launch of Illumina, Inc. (ILMN) SNP Genotyping Services 2/17/2009 8:49:44 AM
    Ocimum Biosolutions B.V. (Formerly known as Isogen Biosolutions B.V.) And Gene Logic Inc. (GLGC) Announce Winners of Genomic Pioneer Awards 10/22/2008 9:09:21 AM
    Gene Logic Inc. (GLGC) and deSciner Enter into a Partnership to Create 'Genomics Gateway' 10/10/2008 9:33:07 AM
    Gene Logic Inc. (GLGC) Renews Agreement with Agilent Technologies Inc. (A) as Certified Service Provider 7/14/2008 8:31:37 AM
    Gene Logic Inc. (GLGC) to Provide EPA Access to Software and Databases to Explore Strategies for Chemical Toxicity Screening 1/28/2008 8:47:33 AM